Patients from eight different cancer types (bladder, breast, colon, endometrial, glioma, stomach, lung and head and neck) with mutations in this interface had significantly higher levels of TP53 protein than those with other or no TP53 mutations (Fig H in S1 Text). Here, TP53 is linked to glioma.